133 related articles for article (PubMed ID: 21971449)
1. Hippocampal network alterations in Alzheimer's disease and Down syndrome: from structure to therapy.
Sanchez MM; Moghadam S; Naik P; Martin KJ; Salehi A
J Alzheimers Dis; 2011; 26 Suppl 3():29-47. PubMed ID: 21971449
[TBL] [Abstract][Full Text] [Related]
2. Neurobiological elements of cognitive dysfunction in down syndrome: exploring the role of APP.
Millan Sanchez M; Heyn SN; Das D; Moghadam S; Martin KJ; Salehi A
Biol Psychiatry; 2012 Mar; 71(5):403-9. PubMed ID: 21945306
[TBL] [Abstract][Full Text] [Related]
3. Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care.
Trillo L; Das D; Hsieh W; Medina B; Moghadam S; Lin B; Dang V; Sanchez MM; De Miguel Z; Ashford JW; Salehi A
Neurosci Biobehav Rev; 2013 Sep; 37(8):1363-79. PubMed ID: 23707776
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models?
Marchetti C; Marie H
Rev Neurosci; 2011; 22(4):373-402. PubMed ID: 21732714
[TBL] [Abstract][Full Text] [Related]
5. Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease.
Goutagny R; Gu N; Cavanagh C; Jackson J; Chabot JG; Quirion R; Krantic S; Williams S
Eur J Neurosci; 2013 Jun; 37(12):1896-902. PubMed ID: 23773058
[TBL] [Abstract][Full Text] [Related]
6. Activation of large-conductance Ca(2+)-activated K(+) channels depresses basal synaptic transmission in the hippocampal CA1 area in APP (swe/ind) TgCRND8 mice.
Ye H; Jalini S; Mylvaganam S; Carlen P
Neurobiol Aging; 2010 Apr; 31(4):591-604. PubMed ID: 18547679
[TBL] [Abstract][Full Text] [Related]
7. Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice.
Kern DS; Maclean KN; Jiang H; Synder EY; Sladek JR; Bjugstad KB
Cell Transplant; 2011; 20(3):371-9. PubMed ID: 20875225
[TBL] [Abstract][Full Text] [Related]
8. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
Kalinin S; Gavrilyuk V; Polak PE; Vasser R; Zhao J; Heneka MT; Feinstein DL
Neurobiol Aging; 2007 Aug; 28(8):1206-14. PubMed ID: 16837104
[TBL] [Abstract][Full Text] [Related]
9. Vascular fibrosis and calcification in the hippocampus in aging, Alzheimer disease, and Down syndrome.
Wegiel J; Kuchna I; Wisniewski T; de Leon MJ; Reisberg B; Pirttila T; Kivimaki T; Lehtimaki T
Acta Neuropathol; 2002 Apr; 103(4):333-43. PubMed ID: 11904752
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
11. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.
Giménez-Llort L; Blázquez G; Cañete T; Johansson B; Oddo S; Tobeña A; LaFerla FM; Fernández-Teruel A
Neurosci Biobehav Rev; 2007; 31(1):125-47. PubMed ID: 17055579
[TBL] [Abstract][Full Text] [Related]
12. Human and mouse model cognitive phenotypes in Down syndrome: implications for assessment.
Edgin JO; Mason GM; Spanò G; Fernández A; Nadel L
Prog Brain Res; 2012; 197():123-51. PubMed ID: 22541291
[TBL] [Abstract][Full Text] [Related]
13. Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.
Reilly JF; Games D; Rydel RE; Freedman S; Schenk D; Young WG; Morrison JH; Bloom FE
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4837-42. PubMed ID: 12697936
[TBL] [Abstract][Full Text] [Related]
14. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
[TBL] [Abstract][Full Text] [Related]
15. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein-I and -III expression in animal models of Alzheimer disease.
Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J
Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170
[TBL] [Abstract][Full Text] [Related]
17. Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems.
Price DL; Wong PC; Borchelt DR; Pardo CA; Thinakaran G; Doan AP; Lee MK; Martin LJ; Sisodia SS
Rev Neurol (Paris); 1997 Sep; 153(8-9):484-95. PubMed ID: 9683997
[TBL] [Abstract][Full Text] [Related]
18. Alterations of brain circuits in Down syndrome murine models.
Gotti S; Caricati E; Panzica G
J Chem Neuroanat; 2011 Dec; 42(4):317-26. PubMed ID: 21946025
[TBL] [Abstract][Full Text] [Related]
19. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
20. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
Toledo EM; Inestrosa NC
Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
